DelveInsight’s Hemodynamic Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading hemodynamic monitoring systems companies’ market shares, ...

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, has received CE Mark for its HemoSphere advanced ...

The U.S. FDA granted 510(k) clearance for Clew Medical Ltd.’s artificial intelligence (AI)-based solution that can predict hemodynamic instability in ICU patients eight hours in advance of ...

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Caretaker Medical, a pioneer in wireless “beat by beat” continuous, non-invasive, advanced patient monitoring, today announced U.S. Food and Drug Administration ...

Chronicle Offers Management to Patients With Advanced Signs of HF COMPASS-HF evaluates a strategy of heart failure management directed by an implantable continuous hemodynamic monitor compared with ...

WHITE PLAINS, N.Y., Feb. 17, 2026 /PRNewswire/ -- Retia Medical today announced that the U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for Argos Infinity (TM), the company's ...

Global Hemodynamic Monitoring Market valued at $1.04 billion (2021), is set to witness a growth rate of 6% in the next 5 years. Growing cases of cardiovascular diseases, COPD and other respiratory ...

IRVINE, Calif., April 19, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, ...

NEWTON, Mass.--(BUSINESS WIRE)--Cheetah Medical, a rapidly growing medical device company, announced the results of a major new study conducted by Drs. Heath Latham and Steven Q. Simpson from the ...

Noninvasive hemodynamic monitoring company Cheetah Medical is touting results from a new study showing that using the company's technology to assess fluid responsiveness could save hospitals time and ...